Surgical Treatment of Morbid Obesity

Lee, Chang Min; Kim, Jong Han

doi:2017.17.2.72

Korean J Helicobacter Up Gastrointest Res > Volume 17(2); 2017 > Article

Review

The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2017;17(2):72-78.
DOI: https://doi.org/10.7704/kjhugr.2017.17.2.72 Published online June 10, 2017.

Surgical Treatment of Morbid Obesity

Chang Min Lee, Jong Han Kim

Division of Upper Gastrointestinal Surgery, Department of Surgery, Korea University College of Medicine, Seoul, Korea. ppongttai@gmail.com

고도 비만의 외과적 치료

이창민, 김종한

고려대학교 의과대학 외과학교실 상부위장관 외과

Received: 30 March 2017 • Revised: 8 May 2017 • Accepted: 9 May 2017

Abstract

Surgical therapy is currently the only effective treatment for morbid obesity. Bariatric surgery traditionally consisted of laparoscopic gastric bypass and adjustable gastric banding in numerous patients. Recently, laparoscopic sleeve gastrectomy has become the most common bariatric procedure performed. Publicly issued medical-accident had a critical effect on the incidence and trend of bariatric surgery in Korea. Recently, the trend of bariatric surgery has shifted from weight loss surgery to metabolic surgery. The onco-metabolic surgical concept needs to be considered for gastric cancer patients with type II diabetes mellitus (DM) who are expecting a favorable prognosis. Therefore, for gastric cancer patients with type II DM, curative gastrectomy with long-limb bypass reconstruction could be a more attractive option for long-term diabetes control. Although a few centers are currently applying this reconstruction method for some early gastric cancer cases, further studies are needed.

Key Words: Bariatric surgery; Diabetes mellitus; Metabolism; Morbid obesity